Consistent with the in vitro data, T5224 supplementation reduced the TWEAK/Fn14-driven metastasis of TNBC cells in vivo without affecting tumour growth (Supplementary Fig. 11d–g). This evidence concerns the gene TNFSF12 and neoplasm.